X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1196) 1196
Publication (116) 116
Book Review (18) 18
Newsletter (12) 12
Conference Proceeding (9) 9
Book Chapter (8) 8
Magazine Article (6) 6
Newspaper Article (4) 4
Book / eBook (3) 3
Web Resource (3) 3
Reference (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (999) 999
infant (625) 625
index medicus (609) 609
rotavirus infections - prevention & control (516) 516
vaccines (465) 465
rotavirus vaccines - adverse effects (464) 464
rotavirus (436) 436
immunology (418) 418
children (398) 398
diarrhea (340) 340
infants (334) 334
female (331) 331
vaccination (327) 327
rotavirus vaccines - administration & dosage (321) 321
gastroenteritis (310) 310
male (307) 307
immunization (292) 292
child, preschool (285) 285
safety (284) 284
efficacy (258) 258
intussusception (256) 256
viruses (252) 252
pediatrics (251) 251
rotavirus - immunology (240) 240
rotavirus vaccines - immunology (232) 232
infectious diseases (219) 219
medicine, research & experimental (207) 207
rotavirus vaccine (198) 198
vaccines, attenuated - adverse effects (194) 194
infant, newborn (188) 188
rotavirus infections - epidemiology (180) 180
animals (175) 175
child (169) 169
gastroenteritis - prevention & control (169) 169
prevention (166) 166
united-states (164) 164
rotavirus vaccines (158) 158
vaccines, attenuated - administration & dosage (156) 156
allergy and immunology (154) 154
vaccine (154) 154
disease (149) 149
intussusception - etiology (146) 146
infection (145) 145
rotavirus infections (144) 144
vaccines, attenuated - immunology (139) 139
health aspects (138) 138
immunogenicity (135) 135
rotavirus infections - immunology (132) 132
gastroenteritis - virology (128) 128
intussusception - epidemiology (128) 128
surveillance (112) 112
administration, oral (109) 109
double-blind method (109) 109
medicine, general & internal (109) 109
mortality (108) 108
epidemiology (105) 105
young-children (105) 105
children & youth (102) 102
public health (102) 102
double-blind (99) 99
incidence (98) 98
age (94) 94
rotavirus vaccines - therapeutic use (94) 94
immunization schedule (93) 93
risk (93) 93
rotavirus infections - virology (93) 93
analysis (92) 92
developing countries (92) 92
infections (92) 92
united states (90) 90
viral vaccines - adverse effects (89) 89
research (85) 85
antibodies, viral - blood (83) 83
gastroenteritis - epidemiology (83) 83
biotechnology & applied microbiology (82) 82
hospitalization (82) 82
risk factors (80) 80
microbiology (78) 78
studies (77) 77
viral vaccines (76) 76
pharmacology & pharmacy (74) 74
clinical trials (73) 73
intussusception - chemically induced (73) 73
vaccination - adverse effects (73) 73
viral vaccines - immunology (72) 72
protection (71) 71
diarrhea - prevention & control (70) 70
rotavirus vaccination (70) 70
abridged index medicus (69) 69
adult (68) 68
clinical trials as topic (68) 68
cost-effectiveness (66) 66
diarrhea - virology (66) 66
rotavirus - genetics (66) 66
rotavirus - isolation & purification (66) 66
rotavirus vaccines - economics (66) 66
cost-benefit analysis (64) 64
medical research (64) 64
retrospective studies (62) 62
vaccination - methods (59) 59
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1198) 1198
French (10) 10
Spanish (9) 9
Japanese (3) 3
Chinese (2) 2
German (2) 2
Italian (2) 2
Russian (2) 2
Swedish (2) 2
Polish (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 01/2010, Volume 362, Issue 4, pp. 289 - 298
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2006, Volume 354, Issue 1, pp. 23 - 33
In this randomized trial, the clinical efficacy of an oral, live pentavalent human–bovine reassortant vaccine was estimated to be 98.0 percent against severe... 
TRIAL | MEDICINE, GENERAL & INTERNAL | INTUSSUSCEPTION | PROTECTION | INFANTS | DISEASE | IMPLEMENTATION | INFECTION | GASTROENTERITIS | ASSOCIATION | CHILDREN | Health Resources - utilization | Intussusception - etiology | Humans | Rotavirus - immunology | Infant | Male | Risk | Gastroenteritis - virology | Antibodies, Viral - blood | Cattle | Vaccines, Attenuated - administration & dosage | Rotavirus Vaccines - adverse effects | Female | Rotavirus Vaccines - administration & dosage | Diarrhea, Infantile - prevention & control | Double-Blind Method | Rotavirus Vaccines - immunology | Administration, Oral | Diarrhea, Infantile - virology | Hospitalization | Gastroenteritis - prevention & control | Vaccines, Attenuated - immunology | Animals | Gastrointestinal Hemorrhage - etiology | Fever - etiology | Reassortant Viruses | Immunoglobulin A - blood | Rotavirus - classification | Vaccines, Attenuated - adverse effects | Rotavirus Infections - prevention & control | Care and treatment | Usage | Viral vaccines | Gastroenteritis | Rotavirus infections | Babies | Vaccines | Health risk assessment | Medical disorders | Medical treatment | Immunoglobulin A/blood | Antibodies; Viral/blood | Vaccines; Attenuated/administration & dosage/adverse effects/immunology | Diarrhea; Infantile/prevention & control/virology | Fever/etiology | Rotavirus/classification/immunology | Rotavirus Vaccines/administration & dosage/adverse effects/immunology | Administration; Oral | Health Resources/utilization | Intussusception/etiology | Gastrointestinal Hemorrhage/etiology | Rotavirus Infections/prevention & control | Gastroenteritis/prevention & control/virology
Journal Article
Vaccine, ISSN 0264-410X, 2015, Volume 33, Issue 36, pp. 4398 - 4405
Abstract The Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) conduct post-licensure vaccine safety monitoring... 
Allergy and Immunology | Adverse reaction | Vaccine Adverse Event Reporting System (VAERS) | Vaccination | Passive surveillance | Vaccine safety | Vaccine adverse event | Adverse event following immunization | Adverse effect | Spontaneous reporting | HUMAN-PAPILLOMAVIRUS VACCINE | UNITED-STATES | SIGNAL | MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNIZATION SAFETY | A H1N1 2009 | FEBRILE SEIZURES | IMMUNOLOGY | ROTAVIRUS VACCINATION | SURVEILLANCE | INFLUENZA VACCINE | MONOVALENT VACCINES | United States - epidemiology | Vaccines - adverse effects | Adverse Drug Reaction Reporting Systems | Humans | Product Surveillance, Postmarketing | Vaccines - administration & dosage | Centers for Disease Control and Prevention (U.S.) | United States Food and Drug Administration | Drug-Related Side Effects and Adverse Reactions - epidemiology | Drug-Related Side Effects and Adverse Reactions - pathology | Medical care | Safety and security measures | Vaccines | Analysis | Quality management | Health care | Health facilities | Immunization | Pandemics | Funding | Licenses | Clinical trials | School attendance | Disease control | International organizations | Hypotheses | Parents & parenting | Surveillance | Influenza | Conflicts of interest | Electronic data interchange | Public health | vaccine safety | adverse effect | adverse reaction | adverse event following immunization | vaccine adverse event | passive surveillance | spontaneous reporting
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 11/2013, Volume 57, Issue 10, pp. 1427 - 1434
Journal Article
Vaccine, ISSN 0264-410X, 2016, Volume 35, Issue 3, pp. 452 - 458
Highlights • DTaP-IPV-HB-PRP-T immunogenicity is similar when given concomitantly with a meningococcal C conjugate vaccine or alone. • The safety profile of... 
Allergy and Immunology | Co-administration | Meningococcal C | Safety | Immunogenicity | Vaccination | Hexavalent | MEDICINE, RESEARCH & EXPERIMENTAL | DIFFERENCE | COMBINATION VACCINES | B VACCINE | IMMUNOLOGY | TETANUS TOXOID CONJUGATE | Haemophilus Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - administration & dosage | Humans | Infant | Haemophilus Vaccines - administration & dosage | Pneumococcal Vaccines - administration & dosage | Healthy Volunteers | Vaccines, Combined - administration & dosage | Vaccines, Combined - immunology | Meningococcal Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - immunology | Hepatitis B Antibodies - blood | Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage | Diphtheria-Tetanus-Pertussis Vaccine - immunology | Immunization Schedule | Antibodies, Bacterial - blood | Rotavirus Vaccines - administration & dosage | Diphtheria-Tetanus-Pertussis Vaccine - adverse effects | Hepatitis B Vaccines - administration & dosage | Haemophilus Vaccines - immunology | Vaccines, Combined - adverse effects | Hepatitis B Vaccines - adverse effects | Finland | Poliovirus Vaccine, Inactivated - adverse effects | Hepatitis B Vaccines - immunology | Meningococcal Vaccines - immunology | Meningococcal Vaccines - administration & dosage | Usage | Infants | Vaccines | Antigens | Hepatitis | Immunization | Pain | Poliomyelitis | Viruses | Tetanus | Diphtheria | Age | Whooping cough
Journal Article
Vaccine, ISSN 0264-410X, 2017, Volume 35, Issue 23, pp. 3041 - 3049
Highlights • PASS evaluate identified, potential or theoretical risks of medicinal products. • PASS contribute to the benefit-risk evaluation of vaccines in... 
Allergy and Immunology | Pharmacoepidemiology | Adverse event | Vaccine | Safety | PASS | Challenges | MEDICINE, RESEARCH & EXPERIMENTAL | DESIGN | INTUSSUSCEPTION | MMRV VACCINATION | RISK | IMMUNOLOGY | ROTAVIRUS VACCINATION | NARCOLEPSY | FEBRILE CONVULSIONS | CLINICAL-TRIALS | POOLED ANALYSIS | COHORT | Chickenpox Vaccine - adverse effects | Risk Assessment | Adverse Drug Reaction Reporting Systems | Technology, Pharmaceutical - legislation & jurisprudence | Drug Industry - legislation & jurisprudence | Humans | Vaccination | Influenza Vaccines - adverse effects | Technology, Pharmaceutical - methods | Measles-Mumps-Rubella Vaccine - adverse effects | Vaccines - adverse effects | Vaccines, Combined - adverse effects | Technology, Pharmaceutical - organization & administration | Malaria Vaccines - adverse effects | Vaccines, Attenuated | Papillomavirus Vaccines - adverse effects | Rotavirus Vaccines - adverse effects | Vaccines - administration & dosage | Medicine, Experimental | Medical research | Biological products industry | Safety and security measures | Vaccines | Influenza vaccines | Papillomavirus infections | Rubella | Immunization | Regulators | Malaria | Health risks | Feasibility studies | Pharmacology | FDA approval | Data sources | Incidence | Studies | Side effects | Databases | Comparators | Measles | Influenza | Varicella | Mumps | Product safety | Risk management | Public health
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 8, pp. 843 - 853
Summary Background Efficacy of live oral rotavirus vaccines is reduced in low-income compared with high-income settings. Parenteral non-replicating rotavirus... 
Infectious Disease | STRAINS | INFECTIOUS DISEASES | PROTECTIVE IMMUNITY | EFFICACY | DISEASE | ADULTS | DEVELOPING-COUNTRIES | CHILDREN | RNA-Binding Proteins - genetics | Immunoglobulin G - blood | Vaccines, Subunit - genetics | Humans | Child, Preschool | Infant | Male | Antibodies, Viral - blood | Drug-Related Side Effects and Adverse Reactions - pathology | Rotavirus Vaccines - adverse effects | Female | Vaccines, Subunit - adverse effects | Placebos - administration & dosage | Rotavirus Vaccines - administration & dosage | Viral Nonstructural Proteins - immunology | Double-Blind Method | Rotavirus Vaccines - immunology | RNA-Binding Proteins - immunology | Viral Nonstructural Proteins - genetics | Vaccines, Subunit - immunology | Drug-Related Side Effects and Adverse Reactions - epidemiology | Rotavirus Vaccines - genetics | Vaccines, Subunit - administration & dosage | Immunoglobulin A - blood | South Africa | Clinical trials | Vaccines | Toddlers | Analysis | Vaccination | Low income groups | Disease | Immunoglobulin G | Medical services | Parents | Income | Homology | Viruses | Infants | Immunoglobulin A | Epidemiology | Tropical diseases | Proteins | Randomization | Replicating | Poliomyelitis | Human immunodeficiency virus--HIV | Licensed products | Safety | Malnutrition | Immunoglobulins | Injection | Typhoid | Studies | Charities | Immunogenicity | Cholera | Index Medicus
Journal Article